RxDoctor Payments DataLook up a doctor →

Ellen Kim

Family Medicine · Albuquerque, NMNPI 1275600637

Payments from drug & device makers

$2,193,113in general payments, 2019–2025

Across 476 payments — averaging $4607.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1.1M
  • Modernatx, Inc.$357K
  • Merck$261K
  • Novartis$143K
  • GSK$126K
  • Eli Lilly$70K
  • plus $146K from 9 others
$198in research payments, 2019–2025

Across 1 payment — averaging $198.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$198

What the payments were for

  • Food & beverage$36100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)202$1,091,122
Modernatx, Inc.39$356,709
Merck119$260,661
Novartis8$143,378
GSK21$126,175
Eli Lilly7$69,515
Regeneron11$36,201
Pfizer12$23,310
Takeda Pharmaceuticals U.S.A., Inc.10$18,931
Amgen1$16,324
Ferring International Pharmascience Center US1$16,125
GRT US Holding, Inc.32$15,716
H. Lundbeck A S5$14,000
Swedish Orphan Biovitrum AB7$4,916
E.r. Squibb & Sons, L.L.C.1$30

How this compares

$2,193,113 in reported general payments places this provider in the 95th percentile of 717 family medicine providers in New Mexico.

See all family medicine providers in New Mexico

Other family medicine in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →